176 related articles for article (PubMed ID: 3285294)
1. ras oncogene activation in human ovarian carcinoma.
van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
[TBL] [Abstract][Full Text] [Related]
2. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation.
Dmitrovsky E; Murty VV; Moy D; Miller WH; Nanus D; Albino AP; Samaniego F; Bosl G; Chaganti RS
Oncogene; 1990 Apr; 5(4):543-8. PubMed ID: 2183156
[TBL] [Abstract][Full Text] [Related]
3. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
[TBL] [Abstract][Full Text] [Related]
4. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
[TBL] [Abstract][Full Text] [Related]
5. Amplification and enhanced expression of the c-Ki-ras2 protooncogene in human embryonal carcinomas.
Wang LC; Vass W; Gao CL; Chang KS
Cancer Res; 1987 Aug; 47(15):4192-8. PubMed ID: 2886216
[TBL] [Abstract][Full Text] [Related]
6. Evidence against ras activation in human ovarian carcinomas.
Haas M; Isakov J; Howell SB
Mol Biol Med; 1987 Oct; 4(5):265-75. PubMed ID: 3320675
[TBL] [Abstract][Full Text] [Related]
7. K-ras activation in neoplasms of the human female reproductive tract.
Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
[TBL] [Abstract][Full Text] [Related]
8. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
9. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract][Full Text] [Related]
10. High frequency of mas oncogene activation detected in the NIH3T3 tumorigenicity assay.
van 't Veer LJ; van den Berg-Bakker LA; Hermens RP; Deprez RL; Schrier PI
Oncogene Res; 1988; 3(3):247-54. PubMed ID: 3060802
[TBL] [Abstract][Full Text] [Related]
11. Preferential and novel activation of H-ras in human bladder carcinomas.
Visvanathan KV; Pocock RD; Summerhayes IC
Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
[TBL] [Abstract][Full Text] [Related]
12. A cell line from a human ovarian carcinoma with amplification of the K-ras gene.
Filmus J; Trent JM; Pullano R; Buick RN
Cancer Res; 1986 Oct; 46(10):5179-82. PubMed ID: 3756872
[TBL] [Abstract][Full Text] [Related]
13. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
[TBL] [Abstract][Full Text] [Related]
14. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
[TBL] [Abstract][Full Text] [Related]
15. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
16. Analysis of ras gene mutations and methylation state in human leukemias.
Browett PJ; Norton JD
Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
18. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
19. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
20. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW
Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
